NCT06717035

Brief Summary

This clinical study aims to evaluate the non-inferiority of the photochromic DIMS spectacles lenses performance (PDIMS) compared to clear DIMS spectacles lenses (DIMS) in myopia management.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
202

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Jan 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2025Jan 2027

First Submitted

Initial submission to the registry

November 23, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 4, 2024

Completed
29 days until next milestone

Study Start

First participant enrolled

January 2, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2027

Last Updated

December 4, 2024

Status Verified

November 1, 2024

Enrollment Period

2 years

First QC Date

November 23, 2024

Last Update Submit

November 29, 2024

Conditions

Keywords

MyopiaSpectaclesGlassesMyopia ControlPediatricDIMS

Outcome Measures

Primary Outcomes (1)

  • Comparing photochromic DIMS spectacles lenses performance (PDIMS) versus clear DIMS spectacles lenses (DIMS)

    The primary objective of this study is to evaluate the efficacy of photochromic DIMS spectacles lenses performance (PDIMS) compared to clear DIMS spectacles lenses (DIMS) in terms of childhood myopia control (cycloplegic spherical equivalent refraction (SER), axial elongation and choroidal thickness).

    24 months

Secondary Outcomes (1)

  • Performance of photochromic DIMS spectacles lenses performance (PDIMS) compared to clear DIMS spectacles lenses (DIMS)

    24 months

Study Arms (2)

Children on clear DIMS lenses

ACTIVE COMPARATOR

202 children will be recruited at 6 institutions following the rules of inclusion and exclusion criteria. Based on a randomization process defined from the study coordinator, children will be allocated to 2 groups: DIMS and PDIMS. The study will be single blinded, meaning that the investigators are not aware of which type of treatment will be associated with which subjects. Subjects cannot be blinded due to the darkening of PDIMS that allows recognition on the type of lens.

Device: EYE001

Children on photochromic DIMS lenses

ACTIVE COMPARATOR

202 children will be recruited at 6 institutions following the rules of inclusion and exclusion criteria. Based on a randomization process defined from the study coordinator, children will be allocated to 2 groups: DIMS and PDIMS. The study will be single blinded, meaning that the investigators are not aware of which type of treatment will be associated with which subjects. Subjects cannot be blinded due to the darkening of PDIMS that allows recognition on the type of lens.

Device: EYE001

Interventions

EYE001DEVICE

Defocus incorporated multiple segments (DIMS) clear vs DIMS photochromic

Also known as: Defocus incorporated multiple segments (DIMS) lenses
Children on clear DIMS lensesChildren on photochromic DIMS lenses

Eligibility Criteria

Age6 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Subjects must meet all the criteria listed to participate in the study:
  • All ethnicities
  • Age between 6 and 15 years
  • Refraction -0.50D till - 7.00D and astigmatism ≤ 3.00D
  • Anisometropia ≤ 3.00D
  • Best corrected monocular distance high contrast VA ≤ 0.10 logMAR
  • Normal Binocular vision (fusion and stereopsis)

You may not qualify if:

  • Ocular and systemic abnormalities
  • Children who do not cooperate
  • Binocular vision anomalies (strabismus, suppression)
  • Previous use of myopia management treatment (spectacles, atropine, CLs)
  • Neurological disorders
  • Premature infants
  • Children who do not wear their glasses correctly for intermediate and near vision activities
  • No informed consent given by parents of child for participation in the clinical study
  • Subject is allergic to cycloplegic eye drops

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore National Eye Centre

Singapore, 159029, Singapore

Location

Related Publications (2)

  • Lam CS, Tang WC, Lee PH, Zhang HY, Qi H, Hasegawa K, To CH. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol. 2022 Aug;106(8):1110-1114. doi: 10.1136/bjophthalmol-2020-317664. Epub 2021 Mar 17.

    PMID: 33731364BACKGROUND
  • Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020 Mar;104(3):363-368. doi: 10.1136/bjophthalmol-2018-313739. Epub 2019 May 29.

    PMID: 31142465BACKGROUND

MeSH Terms

Conditions

Myopia

Interventions

Lenses

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Intervention Hierarchy (Ancestors)

Optical DevicesEquipment and Supplies

Central Study Contacts

Bryan Sim, MD FRCOphth (UK)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomization: 202 children will be recruited at 6 institutions following the rules of inclusion and exclusion criteria. Based on a randomization process defined from the study coordinator, children will be allocated to 2 groups: DIMS and PDIMS. The study will be single blinded, meaning that the investigators are not aware of which type of treatment will be associated with which subjects. Subjects cannot be blinded due to the darkening of PDIMS that allows recognition on the type of lens.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant

Study Record Dates

First Submitted

November 23, 2024

First Posted

December 4, 2024

Study Start

January 2, 2025

Primary Completion (Estimated)

January 2, 2027

Study Completion (Estimated)

January 2, 2027

Last Updated

December 4, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

Change in spherical equivalent and axial length over time for further trials in future

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
2025-2026
Access Criteria
Interested investigators
More information

Locations